- Home
- STT vs BNTX Comparison
STT vs BNTX Comparison
Compare STT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- BNTX
- Stock Information
- Founded
- STT 1792
- BNTX 2008
- Country
- STT United States
- BNTX Germany
- Employees
- STT N/A
- BNTX N/A
- Industry
- STT Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STT Finance
- BNTX Health Care
- Exchange
- STT Nasdaq
- BNTX Nasdaq
- Market Cap
- STT 32.1B
- BNTX 26.4B
- IPO Year
- STT N/A
- BNTX 2019
- Fundamental
- Price
- STT $111.46
- BNTX $105.04
- Analyst Decision
- STT Buy
- BNTX Strong Buy
- Analyst Count
- STT 13
- BNTX 14
- Target Price
- STT $121.38
- BNTX $139.06
- AVG Volume (30 Days)
- STT 1.7M
- BNTX 647.6K
- Earning Date
- STT 10-17-2025
- BNTX 11-03-2025
- Dividend Yield
- STT 3.02%
- BNTX N/A
- EPS Growth
- STT 49.61
- BNTX N/A
- EPS
- STT 9.43
- BNTX N/A
- Revenue
- STT $13,626,000,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- STT $7.22
- BNTX N/A
- Revenue Next Year
- STT $3.90
- BNTX $13.00
- P/E Ratio
- STT $11.81
- BNTX N/A
- Revenue Growth
- STT 8.59
- BNTX 6.98
- 52 Week Low
- STT $72.81
- BNTX $81.20
- 52 Week High
- STT $118.24
- BNTX $129.27
- Technical
- Relative Strength Index (RSI)
- STT 43.54
- BNTX 55.84
- Support Level
- STT $110.87
- BNTX $101.00
- Resistance Level
- STT $117.00
- BNTX $106.71
- Average True Range (ATR)
- STT 3.24
- BNTX 3.08
- MACD
- STT -0.49
- BNTX 0.43
- Stochastic Oscillator
- STT 50.17
- BNTX 65.13
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.